Peer Review
Cancer Imaging
ISSN 1470-7330
Search site with:PicoSearch


Content
Current Issue
Archive
Related Journals / Articles
Information
Aims and Scope
Editors and Board
Editorial Policy
Instructions for Authors
Copyright Transfer Form
Subscription Information
Advertising
Society
Aims
Membership
Annual Meeting
Communications
Bulletin Board
Send Email to ICIS
e-Med
Visit e-Med Web Site
Journals
Purchase
“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

Should we use MRI to screen women at high-risk of breast cancer?

Abstract

Women with a strong family history of breast cancer are at increased risk of developing the disease themselves. Mammographic surveillance is recommended in the over 40 age group but the evidence of benefit from this strategy is limited until the individual reaches age 50 years. There is increasing evidence from the trials of breast magnetic resonance imaging that women at high risk may benefit from this technique as sensitivity is not dependent on breast density. The Dutch and Canadian studies have reported the sensitivity of MRI to be 71% and 77% compared to mammography which was 40% and 36%, respectively, in asymptomatic high risk cohorts.

Author

F J Gilbert

Contact Details

Corresponding address:
Professor Fiona J Gilbert,
Department of Radiology, University of Aberdeen, Lilian Sutton Building,
Foresterhill, Aberdeen,
AB25 2ZD,
Scotland, UK

Reference

ICIS Cancer Imaging Volume 5 Issue 1
DOI: 10.1102/1470-7330.2005.0022

Date Posted

24 May 2005


Print PDF

Size

63.35 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

1 second

64 Kb/s (ISDN):

7 seconds

33.3 Kb/s (Typical Modem):

15 seconds

Screen PDF

Size

311.97 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

4 seconds

64 Kb/s (ISDN):

38 seconds

33.3 Kb/s (Typical Modem):

1 minute 14 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.

© 2000-2009 International Cancer Imaging Society